BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
Reuters2026/09/15 00:19- BIG Impact Inc completed an investment in AOI Biosciences, a Japan-based diagnostics and drug-discovery company focused on autoimmune diseases.
- AOI Biosciences commercializes proprietary antibody testing with domestic and overseas medical institutions.
- The company is building a drug-discovery platform using quantum-related technology, targeting autoimmune disease and infectious disease programs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How will the 110 trillion KRW AI dividend be distributed? Seoul-based hedge fund pressures Samsung to immediately buy back and cancel preferred shares
A South Korean hedge fund is pressuring Samsung to buy back and cancel its preferred shares, planning to use 73 trillion won of a 110 trillion won return plan for the repurchase, aiming to eliminate a discount of over 25%.
Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support
Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.
LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
